QHR Technologies Inc.
TSX VENTURE : QHR

QHR Technologies Inc.

August 24, 2009 07:52 ET

QHR's Optimed Software Chosen as First Approved Vendor for Saskatchewan EMR Program

KELOWNA, BRITISH COLUMBIA--(Marketwire - Aug. 24, 2009) - QHR Technologies Inc. (TSX VENTURE:QHR) today announced that its electronic medical records ("EMR") division, Optimed Software Corporation ("Optimed"), has successfully achieved "Approved Vendor" status in Saskatchewan effective September 1, 2009. As a result of this approval, physician clinics that choose the Accuro EMR software solution are eligible for provincial reimbursement through the Saskatchewan Medical Association ("SMA") and Ministry of Health EMR program.

Optimed is the first to reach the Approved Vendor status and have its Accuro EMR product become eligible for funding, after having been one of four EMR vendors to reach the Preferred Vendor stage in the SMA's request for proposal ("RFP") process to provide Saskatchewan physicians with a set of approved EMR products.

In announcing the selection of Optimed, Al Hildebrandt, President & CEO commented, "We are very pleased to be recognized by the Saskatchewan EMR program as a leading vendor of EMR software. Optimed, through its parent company QHR Technologies Inc., has strategically invested in the Saskatchewan marketplace since 2006. Between the physicians currently utilizing Accuro EMR and those on legacy systems we acquired, Optimed is already supporting over 50% of the 1,400 eligible physicians in Saskatchewan. We have worked closely with the SMA to develop a thorough understanding of the needs of their members and believe that our proven EMR System will be increasingly regarded as the solution of choice of physicians. We are excited to offer the SMA members our Accuro EMR software and look forward to working with them now and in the future."

Optimed supports over 1,700 physicians in Canada, across British Columbia, Alberta, Saskatchewan, Manitoba and Ontario.

For further information on Optimed, please contact Fred Chapman, General Manager and VP Sales, at 250-979-1717 or fchapman@optimedsoftware.com, or go to the Optimed website at www.optimedsoftware.com.

About QHR Technologies Inc.

QHR operates two business units in distinct markets:

The Electronic Medical Records ("EMR") division offers a suite of medical software modules that provides computer-based medical records for family physicians, medical specialists, and surgeons, as well as administrative modules for billing and patient scheduling, that is a key component of the move throughout Canada to provide electronic healthcare records for all Canadians. The EMR division also provides on-site and off-site (ASP) hosting capabilities.

The Enterprise Management Software ("EMS") division specializes in workforce management software, which consists of integrated payroll, staff scheduling and human resource software, and in customized financial management software built on the Microsoft Dynamics GP platform. These products are targeted at complex healthcare and social services environments.

Al Hildebrandt, President and CEO

Legal Notice Regarding Forward Looking Statements

This news release may contain "forward looking statements" within the meaning of applicable Canadian securities legislation. Forward-looking statements are indicated expectations or intentions. Results from operations in any given period are not necessarily indicative of results to be expected in future periods. QHR is a technology business development enterprise where investment; various trends and factors in the marketplace; and product enhancements must be carefully managed to achieve long-term revenue growth and profitability. These statements are subject to risks that may cause the actual results to be materially different in future periods from those expressed or implied by such forward looking statement. It is our policy not to update forward looking statements.

Further risk information on the Company is available at www.sedar.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information